Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475760 · ClinicalTrials.gov registry record · NA
A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease
A NA study of Chronic Kidney Disease, sponsored by Denver Nephrologists, P.C..
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
- 4
- Study locations
NCT01475760 is a NA study of Chronic Kidney Disease that has completed, run by Denver Nephrologists, P.C.. The registered enrollment target is 167 participants, below the 3,205-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01475760, a NA study of Chronic Kidney Disease, has completed, sponsored by Denver Nephrologists, P.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to determine the efficacy of chitosan chewing gum (K2CG) in reducing serum phosphorus in subjects with chronic kidney disease.
Conditions Studied
Interventions
- OTHER K2CG chewing gum (20mg chitosan)
- OTHER K2CG chewing gum (60mg chitosan)
Study Locations (4)
Arizona
- Southwest Clinical Reserach Institute, LLC - Tempe
Colorado
- Denver Nephrologists, PC - Denver
Idaho
- Pacific Renal Research Institute - Meridian
Texas
- Renal Associates, PA - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475760
The ClinicalTrials.gov registry entry for NCT01475760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,205-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (95% lower). The listed sponsor is Denver Nephrologists, P.C., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which K2CG chewing gum (20mg chitosan) is the first listed.
NCT01475760 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Colorado, Idaho.
Frequently Asked Questions
What is clinical trial NCT01475760 about?
NCT01475760 is a clinical study titled "A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease". The purpose of this study is to determine the efficacy of chitosan chewing gum (K2CG) in reducing serum phosphorus in subjects with chronic kidney disease.
What is the current status of trial NCT01475760?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2011-11. Estimated completion is 2012-03.
What conditions does trial NCT01475760 study?
This clinical trial studies the following conditions: Chronic Kidney Disease.
What interventions are being tested in trial NCT01475760?
The interventions under investigation include: K2CG chewing gum (20mg chitosan) (OTHER), K2CG chewing gum (60mg chitosan) (OTHER).
Who is sponsoring clinical trial NCT01475760?
This trial is sponsored by Denver Nephrologists, P.C., which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01475760 being conducted?
This trial has 4 study locations across Arizona, Colorado, Idaho, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transforming Hemodialysis-Related Vascular Access Education
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.